SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 4,423.10 |
| Enterprise Value ($M) | 3,887.11 |
| Book Value ($M) | 1,464.98 |
| Book Value / Share | 9.01 |
| Price / Book | 3.02 |
| NCAV ($M) | 897.91 |
| NCAV / Share | 5.52 |
| Price / NCAV | 4.93 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | 0.20 |
| Return on Assets (ROA) | 0.17 |
| Return on Equity (ROE) | 0.29 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 2.81 |
| Current Ratio | 3.20 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 1,488.50 |
| Assets | 2,055.57 |
| Liabilities | 590.59 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 1,557.63 |
| Operating Income | 420.64 |
| Net Income | 367.07 |
| Earnings Per Share Basic And Diluted | n/a |
| Earnings Per Share Diluted | n/a |
| Earnings Per Share Basic | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 439.12 |
| Cash from Investing | -111.31 |
| Cash from Financing | -494.14 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Wellington Management Group Llp | 4.30 | -44.60 | |
| 13G | Price T Rowe Associates Inc /md/ | 7.90 | 727.77 | |
| 13G/A | Vanguard Group Inc | 11.52 | 0.00 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 162,831 | 1,272,996 | 12.79 | |
| 402,905 | 1,958,888 | 20.57 | |
| 410,153 | 1,714,423 | 23.92 | |
| 203,067 | 1,095,783 | 18.53 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| AGIO – Agios Pharmaceuticals, Inc. | AKRO – Akero Therapeutics, Inc. |
| ALEC – Alector, Inc. | ALLK – Allakos Inc. |
| ALLO – Allogene Therapeutics, Inc. |
Financial data and stock pages provided by
Fintel.io